July/August 2023: Second-Line Switch to Dolutegravir for Treatment of HIV Infection

Aug 23, 2023

Article and Study Summary: Second-Line Switch to Dolutegravir for Treatment of HIV Infection Published in: N Engl J Med. 2023;388(25):2349-2359 https://www.nejm.org/doi/full/10.1056/NEJMoa2210005 Authors: Ombajo LA, Penner J, Nkuranga J, et al. Summary The...

May/June 2023: Adaptive Strategies for Retention in Care among Persons Living with HIV

Jun 21, 2023

Article and Study Summary: Adaptive Strategies for Retention in Care among Persons Living with HIV Published in: NEJM Evid 2023;2(4) https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200076 Authors: Geng EH, Odeny TA, Montoya LM, et al. Summary This trial used a...

March/April 2023: Comparing risk-based versus universal PrEP delivery during pregnancy — The PrEP Implementation for Mothers in Antenatal Care (PrIMA) study

Apr 18, 2023

Article and Study Summary: Risk-based versus universal PrEP delivery during pregnancy: a cluster randomized trial in Western Kenya from 2018 to 2019 Published in: J Int AIDS Soc. 2023;26(2):e26061. https://onlinelibrary.wiley.com/doi/10.1002/jia2.26061 Authors:...

January/February 2023: A 24-week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

Feb 23, 2023

Article and Study Summary: A 24-week, All-Oral Regimen for Rifampin-Resistant Tuberculosis Published in: N Engl J Med. 2022;387(25):2331-2343. https://www.nejm.org/doi/full/10.1056/NEJMoa2117166 Authors: Nyang’wa B, Berry C, Kazounis E, et al. Summary This...

Nov/Dec 2022: Fee for home delivery and monitoring of antiretroviral therapy for HIV infection compared with standard clinic-based services in South Africa: A randomised controlled trial

Dec 16, 2022

Article and Study Summary: Fee for home delivery and monitoring of antiretroviral therapy for HIV infection compared with standard clinic-based services in South Africa: A randomised controlled trial Published in: Lancet HIV. 2022....

Journal Club